Category: Cannabis Stocks
Buy this cannabis stock for a double, analyst says
Haywood analyst Neal Gilmer maintained a “Buy” rating and $3.25 target on Organigram Holdings (Organigram Global Stock Quote, Chart, News,…
Is Canopy Growth Stock Finally Setting Up for a Real Turnaround?
Canopy Growth (NASDAQ: CGC) has made considerable efforts to turn itself around. Over the past few years, the Canada-based cannabis…
Canopy Growth Is One of the Market’s Most Polarizing Stocks: 3 Scenarios for the Next 12 Months
After years of heavy losses and repeated restructurings, Canopy Growth is showing early signs of stabilization.
Cannabis Revenue Decline Pressures Organigram Earnings Despite Germany Expansion (OGI)
Organigram reported weaker second-quarter revenue and profitability as vape and infused pre-roll sales slowed, while the company positioned its Sanity…
This weed stock is undervalued, analyst says
The analyst expects Trulieve to generate Adjusted EBITDA of US$401.1-million on revenue of US$1.178-billion in fiscal 2026, improving to US$415.8-million…
Here’s why Tilray Brands stock has crashed after cannabis reclassification
Tilray Brands stock price crashed to its lowest level since August last year despite the recent US policy change that…
Is Tilray the Best Value Play in the $7.4 Billion Cannabis Beverage Market?
Although cannabis stocks have not performed well over the past five years, there is still some hope left for the…
Why Tilray’s Marijuana Rescheduling Sizzle Has Fizzled
Rescheduling does matter greatly. Moving from Schedule I to Schedule III takes marijuana out of the same league as heroin,…
Cannabis ETFs: Regulatory Momentum Returns Focus
Cannabis stocks often trade less on traditional fundamentals alone and more on changes in policy. Cannabis ETFs are a narrow…
Forget SNDL: HITI is a Significantly Better Cannabis Stock
Every cannabis trader’s feed is buzzing about SNDL (NASDAQ:SNDL) because the company’s Q1 2026 release on April 28, 2026 delivered…
Recent Comments